| Year |
Citation |
Score |
| 2020 |
Hayashi RJ, Winter SS, Dunsmore KP, Devidas M, Chen Z, Wood BL, Hermiston ML, Teachey DT, Perkins SL, Miles RR, Raetz EA, Loh ML, Winick NJ, Carroll WL, Hunger SP, et al. Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2000531. PMID 32552472 DOI: 10.1200/Jco.20.00531 |
0.337 |
|
| 2020 |
Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, et al. Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children. The New England Journal of Medicine. 382: 2207-2219. PMID 32492302 DOI: 10.1056/Nejmoa1915315 |
0.372 |
|
| 2020 |
Viola D, Dona A, Caserta E, Troadec E, Besi F, McDonald T, Ghoda L, Gunes EG, Sanchez JF, Khalife J, Martella M, Karanes C, Htut M, Wang X, Rosenzweig M, ... ... Miles RR, et al. Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting. Leukemia. PMID 32296125 DOI: 10.1038/S41375-020-0810-4 |
0.31 |
|
| 2020 |
Radhakrishnan SV, Luetkens T, Scherer SD, Davis P, Vander Mause ER, Olson ML, Yousef S, Panse J, Abdiche Y, Li KD, Miles RR, Matsui W, Welm AL, Atanackovic D. CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide. Nature Communications. 11: 798. PMID 32034142 DOI: 10.1038/S41467-020-14619-Z |
0.337 |
|
| 2019 |
Panea RI, Love CL, Shingleton JR, Reddy A, Bailey JA, Moormann AM, Otieno JA, Ong'echa JM, Oduor CI, Schroeder KMS, Masalu N, Chao NJ, Agajanian M, Major MB, Fedoriw Y, ... ... Miles RR, et al. The whole genome landscape of Burkitt lymphoma subtypes. Blood. PMID 31558468 DOI: 10.1182/Blood.2019001880 |
0.321 |
|
| 2019 |
Jafek JL, Shakya A, Tai PY, Ibarra A, Kim H, Maddox J, Chumley J, Spangrude GJ, Miles RR, Kelley TW, Tantin D. Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia. Experimental Hematology. PMID 31295506 DOI: 10.1016/J.Exphem.2019.07.002 |
0.322 |
|
| 2019 |
Chisholm KM, Mohlman J, Liew M, Termuhlen A, Cairo MS, Gross TG, Perkins SL, Miles RR. IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials. Pediatric Blood & Cancer. e27770. PMID 31012208 DOI: 10.1002/Pbc.27770 |
0.38 |
|
| 2019 |
Laggis C, Miles R, Stephens DM, Duffy K, Bowen A, Wada D. Cutaneous mantle cell lymphoma histomorphologically mimicking subcutaneous panniculitis-like T-cell lymphoma: Case report. Journal of Cutaneous Pathology. PMID 30957249 DOI: 10.1111/Cup.13471 |
0.389 |
|
| 2019 |
Galardy PJ, Bedekovics T, Macintyre E, Miles RR. Lymphoma diagnostics: getting more from less. British Journal of Haematology. PMID 30784044 DOI: 10.1111/Bjh.15788 |
0.303 |
|
| 2019 |
Pearson ADJ, Scobie N, Norga K, Ligas F, Chiodin D, Burke A, Minard-Colin V, Adamson P, Marshall LV, Balakumaran A, Benettaib B, Bhargava P, Bollard CM, Bolotin E, Bomken S, ... ... Miles RR, et al. ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children. European Journal of Cancer (Oxford, England : 1990). 110: 74-85. PMID 30772656 DOI: 10.1016/J.Ejca.2019.01.013 |
0.376 |
|
| 2019 |
Chu Y, Lee S, Shah T, Yin C, Barth M, Miles RR, Ayello J, Morris E, Harrison L, Van de Ven C, Galardy P, Goldman SC, Lim MS, Hermiston M, McAllister-Lucas LM, et al. Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation, proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model. Oncoimmunology. 8: e1512455. PMID 30546948 DOI: 10.1080/2162402X.2018.1512455 |
0.399 |
|
| 2018 |
Elkeeb D, Hopkins Z, Miles RR, Halwani A, Wada D. Ominous cutaneous presentation of acute myeloid leukemia without peripheral blood involvement upon initial presentation and relapse: case report and literature review. European Journal of Dermatology : Ejd. 28: 809-817. PMID 30698150 DOI: 10.1684/Ejd.2018.3463 |
0.308 |
|
| 2018 |
Yan D, Pomicter AD, Tantravahi S, Mason CC, Senina AV, Ahmann JM, Wang Q, Than H, Patel AB, Heaton W, Eiring AM, Clair PM, Gantz KC, Redwine HM, Swierczek SI, ... ... Miles RR, et al. Nuclear-cytoplasmic transport is a therapeutic target in myelofibrosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30563936 DOI: 10.1158/1078-0432.Ccr-18-0959 |
0.304 |
|
| 2018 |
Borga C, Park G, Foster C, Burroughs-Garcia J, Marchesin M, Shah R, Hasan A, Ahmed ST, Bresolin S, Batchelor L, Scordino T, Miles RR, Te Kronnie G, Regens JL, Frazer JK. Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis. Leukemia. PMID 30111845 DOI: 10.1038/S41375-018-0226-6 |
0.357 |
|
| 2018 |
Xu X, Paxton CN, Hayashi RJ, Perkins SL, Miles RR. 15. Genomic and clinical characterization of early T-cell precursor acute lymphoblastic lymphoma (ETP-LBL) Cancer Genetics and Cytogenetics. 41. DOI: 10.1016/J.Cancergen.2018.04.076 |
0.346 |
|
| 2017 |
Zabriskie MS, Antelope O, Verma AR, Draper LR, Eide CA, Pomicter AD, Tran TH, Druker BJ, Tyner JW, Miles RR, Graham JM, Hwang JY, Varley KE, Toydemir RM, Deininger MW, et al. A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia. Haematologica. PMID 29284681 DOI: 10.3324/Haematol.2017.165282 |
0.336 |
|
| 2017 |
Bouska A, Bi C, Lone W, Zhang W, Kedwaii A, Heavican T, Lachel CM, Yu J, Ferro R, Eldorghamy N, Greiner TC, Vose J, Weisenburger DD, Gascoyne RD, Rosenwald A, ... ... Miles RR, et al. Adult High Grade B-cell Lymphoma with Burkitt Lymphoma Signature: Genomic features and Potential Therapeutic Targets. Blood. PMID 28801451 DOI: 10.1182/Blood-2017-02-767335 |
0.405 |
|
| 2017 |
Promod ST, Johnson DP, Bennett SE, Dennis EM, Banowsky BG, Jones SS, Shearstone JR, Quayle SN, Min C, Jarpe M, Mosbruger T, Pomicter AD, Miles RR, Chen WY, Bhalla KN, et al. HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia. Leukemia. PMID 28579617 DOI: 10.1038/Leu.2017.174 |
0.349 |
|
| 2017 |
Lee S, Day NS, Miles RR, Perkins SL, Lim MS, Ayello J, van de Ven C, Harrison L, El-Mallawany NK, Goldman S, Cairo MS. Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report. British Journal of Haematology. PMID 28474336 DOI: 10.1111/Bjh.14604 |
0.365 |
|
| 2017 |
Wallace JA, Kagele DA, Eiring AM, Kim CN, Hu R, Runtsch MC, Alexander M, Huffaker TB, Lee SH, Patel AB, Mosbruger TL, Voth W, Rao DS, Miles RR, Round JL, et al. miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response. Blood. PMID 28432220 DOI: 10.1182/Blood-2016-09-740209 |
0.31 |
|
| 2017 |
Lee S, Luo W, Shah T, Yin C, O'Connell T, Chung TH, Perkins SL, Miles RR, Ayello J, Morris E, Harrison L, van de Ven C, Cairo MS. The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL. Oncotarget. PMID 28427156 DOI: 10.18632/Oncotarget.15711 |
0.391 |
|
| 2017 |
Patel S, Mason CC, Glenn MJ, Paxton CN, South ST, Cessna MH, Asch J, Cobain EF, Bixby DL, Smith LB, Reshmi S, Gastier-Foster JM, Schiffman JD, Miles RR. Genomic analysis of adult B-ALL identifies potential markers of shorter survival. Leukemia Research. 56: 44-51. PMID 28193567 DOI: 10.1016/J.Leukres.2017.01.034 |
0.394 |
|
| 2016 |
Meyer JA, Zhou D, Mason CC, Downie JM, Rodic V, Abromowitch M, Wistinghausen B, Termuhlen AM, Angiolillo AL, Perkins SL, Barnette P, Schiffman JD, Miles RR. Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues. Pediatric Blood & Cancer. PMID 27957801 DOI: 10.1002/Pbc.26363 |
0.339 |
|
| 2016 |
Modzelewska K, Boer EF, Mosbruger TL, Picard D, Anderson D, Miles RR, Kroll M, Oslund W, Pysher TJ, Schiffman JD, Jensen R, Jette CA, Huang A, Stewart RA. MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells. Cell Reports. 17: 1255-1264. PMID 27783941 DOI: 10.1016/J.Celrep.2016.09.081 |
0.302 |
|
| 2016 |
Miles RR, Shah RK, Frazer JK. Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma. British Journal of Haematology. 173: 582-96. PMID 26969846 DOI: 10.1111/Bjh.14011 |
0.328 |
|
| 2016 |
Luo C, Deng Z, Li L, Clayton F, Chen AL, Wei R, Miles R, Stephens DM, Glenn M, Wang X, Jensen PE, Chen X. Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells. Oncotarget. PMID 26859679 DOI: 10.18632/Oncotarget.7230 |
0.347 |
|
| 2016 |
Meznarich J, Miles R, Paxton CN, Afify Z. Pediatric B-Cell Lymphoma With Lymphoblastic Morphology, TdT Expression, MYC Rearrangement, and Features Overlapping With Burkitt Lymphoma. Pediatric Blood & Cancer. 63: 938-40. PMID 26785246 DOI: 10.1002/Pbc.25907 |
0.413 |
|
| 2016 |
Ippolito T, Gu JJ, Tang G, Mavis C, Miles RR, Hernandez-Ilizaliturri FJ, Barth MJ. Targeting BET Bromodomains in Pre-Clinical Models of Burkitt Lymphoma Blood. 128: 5381-5381. DOI: 10.1182/Blood.V128.22.5381.5381 |
0.361 |
|
| 2016 |
Bouska A, Bi C, Lone W, Zhang W, Kedwaii A, Heavican TB, Lachel CM, Yu J, Fu K, Ferro RA, Eldorghamy N, Greiner TC, Vose JM, Weisenburger DD, Gascoyne RD, ... ... Miles RR, et al. Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target Blood. 128: 4095-4095. DOI: 10.1182/Blood.V128.22.4095.4095 |
0.394 |
|
| 2015 |
Li KD, Miles R, Tripp SR, Glenn MJ, Perkins SL, Salama M. Clinicopathologic evaluation of MYC expression in primary mediastinal (thymic) large B-cell lymphoma. American Journal of Clinical Pathology. 143: 598-604. PMID 25780014 DOI: 10.1309/Ajcpkug0Uqo0Hmdj |
0.35 |
|
| 2015 |
Lee S, Yin C, Ayello J, Morris E, O'Connell T, Harrison L, Ven Cvd, Barth MJ, Miles RR, Galardy PJ, Goldman S, Lim MS, Hermiston ML, McAllister-Lucas L, Giulino-Roth L, et al. Ibrutinib Significantly Prolonged Survival in a Human Burkitt Lymphoma (BL) Xenograft NSG Mouse Model: Ibrutinib May be a Potential Adjuvant Agent in the Treatment of BL Blood. 126: 5117-5117. DOI: 10.1182/Blood.V126.23.5117.5117 |
0.379 |
|
| 2015 |
Lee S, Yin C, Ayello J, Morris E, Harrison L, Ven Cvd, Barth MJ, Miles RR, Galardy PJ, Goldman S, Lim MS, Hermiston ML, McAllister-Lucas L, Giulino-Roth L, Perkins SL, et al. Ibrutinib Alone and in Combination with Dexamethasone and Carfilzomib Significantly Inhibits Cell Proliferation in Primary Mediastinal B-Cell Lymphoma (PMBL): Ibrutinib May be a Future Targeted Agent in Combination Therapy in Patients with PMBL Blood. 126: 4852-4852. DOI: 10.1182/Blood.V126.23.4852.4852 |
0.374 |
|
| 2015 |
Wallace J, Kagele D, Hu R, Runtsch M, Alexander M, Huffaker T, Mosbruger T, Dahlem T, Stephens WZ, Rao DS, Miles RR, Round J, O'Connell RM. Genome-Wide Crispr-Cas9 Screen Identifies Functionally Relevant Micro-RNAs in FLT3-ITD+ AML Blood. 126: 3823-3823. DOI: 10.1182/Blood.V126.23.3823.3823 |
0.356 |
|
| 2015 |
Patel SB, Mason CC, Glenn M, Paxton CN, South ST, Cessna MH, Asch JD, Cobain EF, Bixby D, Smith LB, Reshmi SC, Gastier-Foster JM, Schiffman JD, Miles RR. Genomic Analysis of Adult B-ALL Identifies Changes in Copy Number Profile at Relapse and IKZF1/CDKN2A Co-Deletion at Diagnosis As a Marker of Shorter Survival Blood. 126: 1427-1427. DOI: 10.1182/Blood.V126.23.1427.1427 |
0.392 |
|
| 2015 |
Lee S, Yin C, O'Connell T, Barth M, Ayello J, Harrison L, Ven Cvd, Miles R, Galardy P, Goldman SC, Lim M, Hermiston M, McAllister-Lucas L, Roth LG, Perkins SL, et al. Abstract 2608: Ibrutinib significantly improves survival in a human Burkitt lymphoma (BL) xenograft NSG mouse model: Ibrutinib may be a potential adjuvant agent in the treatment of BL Cancer Research. 75: 2608-2608. DOI: 10.1158/1538-7445.Am2015-2608 |
0.367 |
|
| 2015 |
Patel S, Mason CC, Glenn MJ, Paxton CN, South ST, Cessna MH, Asch J, Cobain EF, Bixby DL, Smith LB, Schiffman JD, Miles RR. Abstract 1723: IKZF1/CDKN2A co-deletion predicts shorter survival in adult B-ALL Cancer Research. 75: 1723-1723. DOI: 10.1158/1538-7445.Am2015-1723 |
0.391 |
|
| 2014 |
Ririe MR, Florell SR, Miles RR, Duffy KL. Secondary diffuse large B-cell lymphoma after chemotherapy for acute myeloid leukemia: looking for the unexpected diagnosis. The American Journal of Dermatopathology. 36: e125-8. PMID 24950422 DOI: 10.1097/Dad.0000000000000027 |
0.381 |
|
| 2014 |
Sangle NA, Miles RR, Kelley TW, Perkins SL. Aberrant expression of multiple T antigens: CD4, CD5, and CD8 on diffuse large B-cell lymphoma. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 22: e45-8. PMID 24185124 DOI: 10.1097/Pai.0B013E31829Cc54C |
0.34 |
|
| 2014 |
Frys S, Czuczman NM, Mavis C, Rolland DCM, Lim MS, Tiwari A, Cairo MS, Miles RR, Barth MJ. Deregulation of the PI3K/Akt Signal Transduction Pathway Is Associated with the Development of Chemotherapy Resistance and Can be Effectively Targeted to Improve Chemoresponsiveness in Burkitt Lymphoma Pre-Clinical Models Blood. 124: 1769-1769. DOI: 10.1182/Blood.V124.21.1769.1769 |
0.365 |
|
| 2014 |
Merzianu M, Cheney R, Groman A, Deeb G, Wilding G, Cotta C, Amre R, Balasubramanian M, Brandao G, Brynes RK, Cherian S, Courville E, Czuchlewski D, Fan G, Grier D, ... ... Miles RR, et al. Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study Blood. 124: 1316-1316. DOI: 10.1182/Blood.V124.21.1316.1316 |
0.305 |
|
| 2014 |
Smock KJ, Agarwal AM, Lim MS, Tripp SR, Miles RR, Patel JL, Abromowitch M, Lones MA, Cairo MS, Perkins SL. Expression of Notch1 and mTOR pathway proteins in pediatric lymphoblastic lymphoma; a Children's Oncology Group report Journal of Hematopathology. 7: 9-14. DOI: 10.1007/S12308-014-0200-9 |
0.401 |
|
| 2013 |
Scotland P, Gaulard P, Love CL, Fataccioli V, Travert M, De Leval L, Weisenburger DD, Czader M, Parihar M, Nair R, Sengar M, Beaven AW, Crow JH, Miles RR, Gordon LI, et al. Whole Genome and Exome Sequencing Defines The Genetic Landscape Of Hepatosplenic T-Cell Lymphoma Blood. 122: 842-842. DOI: 10.1182/Blood.V122.21.842.842 |
0.35 |
|
| 2013 |
Pais F, Barth MJ, Miles RR, Hermiston ML. Histone Deacetylase Inhibitors Enhance Cell Death In Burkitt Lymphoma Cells By Modulating Expression Of The WNT/β-Catenin Pathway and Survivin Blood. 122: 1291-1291. DOI: 10.1182/Blood.V122.21.1291.1291 |
0.357 |
|
| 2012 |
Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WW, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, et al. The genetic landscape of mutations in Burkitt lymphoma. Nature Genetics. 44: 1321-5. PMID 23143597 DOI: 10.1038/Ng.2468 |
0.349 |
|
| 2012 |
Leventaki V, Rodic V, Tripp SR, Bayerl MG, Perkins SL, Barnette P, Schiffman JD, Miles RR. TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases. British Journal of Haematology. 158: 763-71. PMID 22845047 DOI: 10.1111/J.1365-2141.2012.09243.X |
0.319 |
|
| 2012 |
Ridges S, Heaton WL, Joshi D, Choi H, Eiring A, Batchelor L, Choudhry P, Manos EJ, Sofla H, Sanati A, Welborn S, Agarwal A, Spangrude GJ, Miles RR, Cox JE, et al. Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood. 119: 5621-31. PMID 22490804 DOI: 10.1182/Blood-2011-12-398818 |
0.367 |
|
| 2012 |
Miles RR, Arnold S, Cairo MS. Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia. British Journal of Haematology. 156: 730-43. PMID 22260323 DOI: 10.1111/J.1365-2141.2011.09024.X |
0.346 |
|
| 2012 |
Love CL, Jima D, Sun Z, Miles RR, Dunphy CH, Choi WWL, Au WY, Srivastava G, Lugar P, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh K, et al. ID3 Is a Novel Tumor Suppressor Gene in Burkitt Lymphom Blood. 120: 898-898. DOI: 10.1182/Blood.V120.21.898.898 |
0.367 |
|
| 2012 |
Rabin KR, Mason CC, Gurusiddappa S, Leung HE, Morrison DJ, Bhojwani D, Barnette P, South ST, Miles RR, Devidas M, Pession A, Basso G, Potter NE, Kearney L, Moorman AV, et al. IKZF1 and 22q11.22 Deletions and PDGFRA Gains Are Associated with Poor Outcome in Down Syndrome Acute Lymphoblastic Leukemia Blood. 120: 289-289. DOI: 10.1182/Blood.V120.21.289.289 |
0.365 |
|
| 2012 |
Vladimir R, Sheryl T, Bayerl MG, Barnette P, Schiffman JD, Perkins SL, Miles RR. PTEN Expression Is Decreased in Pediatric Burkitt Lymphoma Tissues but Does Not Correlate with AKT Activation. Blood. 120: 2664-2664. DOI: 10.1182/Blood.V120.21.2664.2664 |
0.335 |
|
| 2011 |
Ho AK, Teman CJ, Smith GP, Nightingale DR, Miles RR. Composite mantle cell and diffuse large B-cell lymphoma: report of two cases. International Journal of Surgical Pathology. 19: 643-8. PMID 22090393 DOI: 10.1177/1066896911405656 |
0.394 |
|
| 2011 |
Schiffman JD, Lorimer PD, Rodic V, Jahromi MS, Downie JM, Bayerl MG, Sanmann JN, Althof PA, Sanger WG, Barnette P, Perkins SL, Miles RR. Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression. British Journal of Haematology. 155: 477-86. PMID 21981616 DOI: 10.1111/J.1365-2141.2011.08883.X |
0.356 |
|
| 2011 |
Mangum DS, Shams S, Downie JM, von Schwedler U, Rodic V, Engel M, Barnette P, Frazer JK, Trede N, Pei D, Cheng C, Pui C, Hunger SP, Yang JJ, Miles RR, et al. Focal 22q11.22 Loss Combined with IKZF1 Alterations Predict Very Poor Outcome in Childhood Acute Lymphoblastic Leukemia Blood. 118: 741-741. DOI: 10.1182/Blood.V118.21.741.741 |
0.354 |
|
| 2011 |
Love CL, Jima D, Zhang J, Grubor V, Miles RR, Dunphy CH, Richards KL, Choi WWL, Au WY, Srivastava G, Chadburn A, Gordon LI, Evens AM, Hsi ED, Czader M, et al. Whole Genome and Exome Sequencing Reveals the Genetic Landscape of Burkitt Lymphoma Blood. 118: 433-433. DOI: 10.1182/Blood.V118.21.433.433 |
0.359 |
|
| 2011 |
Cairo MS, Day N, Goldman S, Sanger WG, Harrison L, Lim MS, Miles RR, Perkins SL. Genomic Pathways and Potential Therapeutic Targets in Pediatric Burkitt Lymphoma (PBL): A Children's Oncology Group Report Blood. 118: 1587-1587. DOI: 10.1182/Blood.V118.21.1587.1587 |
0.342 |
|
| 2010 |
Miles RR, Afify Z, Yaish H, Perkins SL. CD56-negative extranodal nasal type NK/T-cell lymphoma. Pediatric Blood & Cancer. 55: 186-9. PMID 20486184 DOI: 10.1002/Pbc.22489 |
0.368 |
|
| 2010 |
Schiffman JD, Lorimer PD, Rodic V, Jahromi MS, Downie JM, Bayerl MG, Perkins SL, Barnette P, Miles RR. High Resolution Genome-Wide Copy Number Analysis of Pediatric Burkitt Lymphoma Identifies Copy Number Alterations In the Majority of Patients Blood. 116: 3123-3123. DOI: 10.1182/Blood.V116.21.3123.3123 |
0.36 |
|
| 2010 |
Downie J, Barnette P, Rodic V, Frazer JK, Trede N, Devidas M, Mullighan C, Hunger S, Miles RR, Schiffman JD. T-Cell Receptor Gene Deletions Are Associated with High Risk Features and Worse Outcome In Childhood Precursor B-Cell Acute Lymphoblastic Leukemia (ALL) Blood. 116: 275-275. DOI: 10.1182/Blood.V116.21.275.275 |
0.396 |
|
| 2010 |
Miles RR, Downie J, Jahromi MS, Joshi D, Rodic V, Muschen M, Yang JJ, Evans WE, Meeker N, Trede N, Frazer JK, Barnette P, Schiffman JD. VPREB1 Deletions Occur Independent of Lambda-Light Chain Rearrangement and Predict Worse Outcome In Pediatric Acute Lymphoblastic Leukemia (ALL) Blood. 116: 273-273. DOI: 10.1182/Blood.V116.21.273.273 |
0.389 |
|
| 2009 |
Miles RR, Mankey CC, Seiler CE, Smith LB, Teruya-Feldstein J, Hsi ED, Elenitoba-Johnson KS, Lim MS. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas. Human Pathology. 40: 1731-7. PMID 19716163 DOI: 10.1016/J.Humpath.2009.05.009 |
0.379 |
|
| 2009 |
Montenegro R, Vu N, Jahromi M, Boucher K, Miles RR, Barnette P, Schiffman JD. Pilot Study of Ethnic Variation in Biological Features of Childhood Acute Lymphoblastic Leukemia (ALL) in Utah. Blood. 114: 4117-4117. DOI: 10.1182/Blood.V114.22.4117.4117 |
0.31 |
|
| 2009 |
Schiffman SD, Downie J, Demarest B, Montenegro R, Rodic V, Barnette P, Miles RR. Novel Use of Molecular Inversion Probes to Interrogate Formalin-Fixed Paraffin-Embedded (FFPE) Samples of Childhood Leukemia. Blood. 114: 1589-1589. DOI: 10.1182/Blood.V114.22.1589.1589 |
0.372 |
|
| 2008 |
Miles RR, Raphael M, McCarthy K, Wotherspoon A, Lones MA, Terrier-Lacombe MJ, Patte C, Gerrard M, Auperin A, Sposto R, Davenport V, Cairo MS, Perkins SL. Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group. Pediatric Blood & Cancer. 51: 369-74. PMID 18493992 DOI: 10.1002/Pbc.21619 |
0.396 |
|
| 2007 |
Miles RR, Cairo MS, Satwani P, Zwick DL, Lones MA, Sposto R, Abromovitch M, Tripp S, Angiolillo AL, Roman E, Davenport V, Perkins SL. Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report. British Journal of Haematology. 138: 506-12. PMID 17659054 DOI: 10.1111/J.1365-2141.2007.06689.X |
0.352 |
|
| Show low-probability matches. |